stars 1 stars 2 stars 3

Release Therapeutics (previously called MaxiVAX) developed a revolutionary, patented, platform technology for the delivery of highly potent therapeutic proteins to the CNS and beyond. Centered on prioritizing patient needs, this novel platform is a promising therapeutic approach, distinguished by its unique CNS-directed functionality and versatile multi-application capabilities.

MaxiVAX Questions

The MaxiVAX annual revenue was $5 million in 2026.

MaxiVAX is based in Genève, Genève.

The NAICS codes for MaxiVAX are [32541, 32, 325, 3254].

The SIC codes for MaxiVAX are [28, 2834, 283].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users